An easy method for developing fusion enabled SARS-CoV2 virus fusion mimic (SCFM), bypassing the need of Bio Safety Level (BSL) facility

Widespread infection due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has led to a global pandemic. Currently, various approaches are being taken up to develop vaccines and therapeutics to treat SARS-CoV2 infection. Consequently, the S protein has become an important target protein...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Abhishek, Dutta, Satarupa, Sharma, Dewanshu, Pal, Amit, Ganguli, Nirmalya, Majumdar, Subeer S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806791/
https://www.ncbi.nlm.nih.gov/pubmed/34436976
http://dx.doi.org/10.1080/21655979.2021.1955509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806791/
https://www.ncbi.nlm.nih.gov/pubmed/34436976
http://dx.doi.org/10.1080/21655979.2021.1955509

Ejemplares similares